Referral to gynaecology for urgent assessment and intravenous fluids is necessary if a pregnant woman experiences severe nausea and vomiting, weight loss, and positive ketones in her urine. This is especially important if the woman has a pre-existing condition that may be affected by prolonged nausea and vomiting, such as diabetes. Caution should be exercised when prescribing metoclopramide to young women due to the risk of extrapyramidal side effects. In this case, hospital management and assessment for intravenous fluids are necessary, and it would not be appropriate to simply reassure the patient and discharge her.

Hyperemesis gravidarum is an extreme form of nausea and vomiting of pregnancy that occurs in around 1% of pregnancies and is most common between 8 and 12 weeks. It is associated with raised beta hCG levels and can be caused by multiple pregnancies, trophoblastic disease, hyperthyroidism, nulliparity, and obesity. Referral criteria for nausea and vomiting in pregnancy include continued symptoms with ketonuria and/or weight loss, a confirmed or suspected comorbidity, and inability to keep down liquids or oral antiemetics. The diagnosis of hyperemesis gravidarum requires the presence of 5% pre-pregnancy weight loss, dehydration, and electrolyte imbalance. Management includes first-line use of antihistamines and oral cyclizine or promethazine, with second-line options of ondansetron and metoclopramide. Admission may be needed for IV hydration. Complications can include Wernicke’s encephalopathy, Mallory-Weiss tear, central pontine myelinolysis, acute tubular necrosis, and fetal growth issues.

If lochia continues for more than 6 weeks, an ultrasound should be performed.

During the puerperium, which is the period of around 6 weeks after childbirth when the woman’s reproductive organs return to their normal state, lochia is the discharge of blood, mucous, and uterine tissue that occurs. It is expected to stop after 4-6 weeks. However, if it persists beyond this time, an ultrasound is necessary to investigate the possibility of retained products of conception.

Lochia refers to the discharge that is released from the vagina after childbirth. This discharge is composed of blood, mucous, and uterine tissue. It is a normal occurrence that can last for up to six weeks following delivery. During this time, the body is working to heal and recover from the physical changes that occurred during pregnancy and childbirth. It is important for new mothers to monitor their lochia and report any unusual changes or symptoms to their healthcare provider.

Managing Chickenpox in Pregnancy: Treatment and Care

Chickenpox is a common childhood disease caused by the varicella-zoster virus. When a pregnant woman contracts chickenpox, it can have detrimental effects on the fetus. However, with proper management and care, the risk of complications can be minimized.

Oral acyclovir is recommended for pregnant women who develop chickenpox within 24 hours of the rash appearing and are at or over 20 weeks’ gestation. Symptomatic relief, such as adequate fluid intake, wearing light cotton clothing, and using paracetamol or soothing moisturizers, can also help alleviate discomfort.

Immediate admission to secondary care is necessary for women with severe symptoms, immunosuppression, haemorrhagic rash, or neurological or respiratory symptoms. Women with mild disease can be cared for in the community and should avoid contact with susceptible individuals until the rash has crusted over.

An immediate fetal growth scan is not necessary unless there are other obstetric indications or concerns. Women who develop chickenpox in pregnancy should have a fetal growth scan at least 5 weeks after the primary infection to detect any possible fetal defects.

Varicella immunisation is not useful in this scenario, as it is a method of passive protection against chickenpox and not a treatment. Termination of pregnancy is not indicated for chickenpox in pregnancy, but the patient should be informed of the risks to the fetus and possible congenital abnormalities.

Overall, proper management and care can help minimize the risk of complications from chickenpox in pregnancy. It is important for pregnant women to seek medical care if symptoms worsen or if there are any concerns.

A study conducted in Norway in 2006 revealed that singleton pregnancies conceived through assisted fertilization had a six-fold higher risk of placenta praevia compared to naturally conceived pregnancies. The risk of placenta previa was also nearly three-fold higher in pregnancies following assisted fertilization for mothers who had conceived both naturally and through assisted fertilization. This abnormal placental placement is believed to be linked to the abnormal ovarian stimulation hormones that occur during IVF. Additionally, the incidence of placenta praevia is associated with previous caesarean sections, multiparity, and previous gynaecological surgeries, while the incidence of other options given increases with the number of previous caesarean sections.

Understanding Placenta Praevia

Placenta praevia is a condition where the placenta is located wholly or partially in the lower uterine segment. It is a relatively rare condition, with only 5% of women having a low-lying placenta when scanned at 16-20 weeks gestation. However, the incidence at delivery is only 0.5%, as most placentas tend to rise away from the cervix.

There are several factors associated with placenta praevia, including multiparity, multiple pregnancy, and embryos implanting on a lower segment scar from a previous caesarean section. Clinical features of placenta praevia include shock in proportion to visible loss, no pain, a non-tender uterus, abnormal lie and presentation, and a usually normal fetal heart. Coagulation problems are rare, and small bleeds may occur before larger ones.

Diagnosis of placenta praevia should not involve digital vaginal examination before an ultrasound, as this may provoke severe haemorrhage. The condition is often picked up on routine 20-week abdominal ultrasounds, but the Royal College of Obstetricians and Gynaecologists recommends the use of transvaginal ultrasound for improved accuracy and safety. Placenta praevia is classified into four grades, with grade IV being the most severe, where the placenta completely covers the internal os.

In summary, placenta praevia is a rare condition that can have serious consequences if not diagnosed and managed appropriately. It is important for healthcare professionals to be aware of the associated factors and clinical features, and to use appropriate diagnostic methods for accurate grading and management.

A woman at 12 weeks gestation is seeking Down syndrome screening. Although her age increases the likelihood of her fetus having Down’s syndrome, it will not affect the initial screening process. The standard screening method involves an ultrasound to evaluate nuchal translucency and serum testing to measure levels of β-human chorionic gonadotropin (β-hCG) and pregnancy-associated plasma protein A (PAPP-A). This combined screening can also detect Edward’s (trisomy 18) and Patau (trisomy 13) syndromes. The triple test, which includes α-fetoprotein, unconjugated oestriol, and β-hCG, is conducted between 15-20 weeks gestation to assess for Down’s syndrome. The quadruple test is also an option for women who have missed the window for combined antenatal screening. A biophysical profile, which evaluates fetal wellbeing through ultrasound detection of heart rate, breathing, movement, tone, and amniotic fluid volume, is used to determine the need for rapid induction of labor.

NICE updated guidelines on antenatal care in 2021, recommending the combined test for screening for Down’s syndrome between 11-13+6 weeks. The test includes nuchal translucency measurement, serum B-HCG, and pregnancy-associated plasma protein A (PAPP-A). The quadruple test is offered between 15-20 weeks for women who book later in pregnancy. Results are interpreted as either a ‘lower chance’ or ‘higher chance’ of chromosomal abnormalities. If a woman receives a ‘higher chance’ result, she may be offered a non-invasive prenatal screening test (NIPT) or a diagnostic test. NIPT analyzes cell-free fetal DNA in the mother’s blood and has high sensitivity and specificity for detecting chromosomal abnormalities. Private companies offer NIPT screening from 10 weeks gestation.

Eclampsia: Diagnosis and Treatment Options

Eclampsia is a serious complication of pregnancy that requires prompt diagnosis and treatment. It is a multisystem disorder characterized by hypertension, proteinuria, and edema, and can lead to seizures and coma if left untreated. The definitive treatment for eclampsia is delivery of the fetus, which should be undertaken as soon as the mother is stabilized.

Seizures should be treated with magnesium sulfate infusions, while phenytoin and diazepam are second-line treatment agents. Pregnant women should be monitored for signs of pre-eclampsia, which can progress to eclampsia if left untreated.

While it is important to rule out other intracranial pathology with CT imaging of the brain, it is not indicated in the treatment of eclampsia. Hydralazine or labetalol infusion is the treatment of choice for hypertension in the setting of pre-eclampsia/eclampsia.

Following an eclamptic episode, around 50% of patients may experience a transient neurological deficit. Therefore, prompt diagnosis and treatment are crucial to prevent serious complications and ensure the best possible outcome for both mother and baby.

The position of the head in relation to the ischial spine is referred to as the station. When the head is at the same level as the ischial spines, the station is considered to be ‘0’. If the station is described as ‘-2’, it means that the head is 2 cm above the ischial spines, while a station of ‘+2’ indicates that the head is 2 cm below the ischial spine.

Induction of labour is a process where labour is artificially started and is required in about 20% of pregnancies. It is indicated in cases of prolonged pregnancy, prelabour premature rupture of the membranes, maternal medical problems, diabetic mother over 38 weeks, pre-eclampsia, obstetric cholestasis, and intrauterine fetal death. The Bishop score is used to assess whether induction of labour is necessary and includes cervical position, consistency, effacement, dilation, and fetal station. A score of less than 5 indicates that labour is unlikely to start without induction, while a score of 8 or more indicates a high chance of spontaneous labour or response to interventions made to induce labour.

Possible methods of induction include membrane sweep, vaginal prostaglandin E2, oral prostaglandin E1, maternal oxytocin infusion, amniotomy, and cervical ripening balloon. The NICE guidelines recommend vaginal prostaglandins or oral misoprostol if the Bishop score is less than or equal to 6, while amniotomy and an intravenous oxytocin infusion are recommended if the score is greater than 6.

The main complication of induction of labour is uterine hyperstimulation, which refers to prolonged and frequent uterine contractions that can interrupt blood flow to the intervillous space and result in fetal hypoxemia and acidemia. Uterine rupture is a rare but serious complication. Management includes removing vaginal prostaglandins and stopping the oxytocin infusion if one has been started, and considering tocolysis.

When managing shoulder dystocia, it is important to call for extra assistance immediately. Avoid using fundal pressure and note that an episiotomy may not always be required. Inducing labor at term can lower the occurrence of shoulder dystocia in women with gestational diabetes. The McRoberts manoeuvre is the preferred initial intervention due to its simplicity, speed, and effectiveness in most cases. These guidelines are based on the RCOG Green-top guideline no. 42 from March 2012 on Shoulder Dystocia.

Shoulder dystocia is a complication that can occur during vaginal delivery when the body of the fetus cannot be delivered after the head has already been delivered. This is usually due to the anterior shoulder of the fetus becoming stuck on the mother’s pubic bone. Shoulder dystocia can cause harm to both the mother and the fetus. Risk factors for shoulder dystocia include fetal macrosomia, high maternal body mass index, diabetes mellitus, and prolonged labor.

If shoulder dystocia is identified, it is important to call for senior help immediately. The McRoberts’ maneuver is often performed, which involves flexing and abducting the mother’s hips to increase the angle of the pelvis and facilitate delivery. An episiotomy may be performed to provide better access for internal maneuvers, but it will not relieve the bony obstruction. Symphysiotomy and the Zavanelli maneuver are not recommended as they can cause significant maternal morbidity. Oxytocin administration is not indicated for shoulder dystocia.

Complications of shoulder dystocia can include postpartum hemorrhage and perineal tears for the mother, and brachial plexus injury and neonatal death for the fetus. It is important to manage shoulder dystocia promptly and appropriately to minimize the risk of these complications.

Antepartum Haemorrhage: Causes and Differential Diagnosis

Antepartum haemorrhage can be caused by various conditions, including placenta praevia, placental abruption, genitourinary infection, and premature labour. Placenta praevia occurs when the placenta covers the internal cervical os, leading to painless vaginal bleeding. Risk factors include maternal age, multiparity, and smoking. Diagnosis is made through ultrasound scanning, and close monitoring is necessary to prevent rebleeding. Placental abruption can be revealed or concealed, with the former causing significant abdominal pain and vaginal bleeding, while the latter is confined within the uterus. Genitourinary infection should also be considered, although this patient’s urinalysis is unremarkable. Premature labour, which is associated with cyclical abdominal pain, is another possible cause of antepartum bleeding. However, this patient presents without pain. A thorough differential diagnosis is crucial in managing antepartum haemorrhage.

Placenta increta is a condition where the chorionic villi, which are normally found in the endometrium, invade the myometrium. This can lead to significant bleeding during vaginal delivery. Placenta increta is more serious than placenta accreta, where the chorionic villi attach to the myometrium but do not invade it, but less severe than placenta percreta, where the chorionic villi invade the perimetrium.

Understanding Placenta Accreta

Placenta accreta is a condition where the placenta attaches to the myometrium instead of the decidua basalis, which can lead to postpartum hemorrhage. This condition is caused by a defective decidua basalis. There are three types of placenta accreta, which are categorized based on the degree of invasion. The first type is accreta, where the chorionic villi attach to the myometrium. The second type is increta, where the chorionic villi invade into the myometrium. The third type is percreta, where the chorionic villi invade through the perimetrium.

There are certain risk factors that increase the likelihood of developing placenta accreta, such as having a previous caesarean section or placenta previa. It is important for healthcare providers to be aware of these risk factors and monitor patients closely during pregnancy and delivery. Early detection and management of placenta accreta can help prevent complications and ensure the best possible outcome for both the mother and baby.

Perineal tears are a common occurrence during childbirth, and the Royal College of Obstetricians and Gynaecologists (RCOG) has developed guidelines to classify them based on their severity. First-degree tears are superficial and do not require any repair, while second-degree tears involve the perineal muscle and require suturing by a midwife or clinician. Third-degree tears involve the anal sphincter complex and require repair in theatre by a trained clinician, with subcategories based on the extent of the tear. Fourth-degree tears involve the anal sphincter complex and rectal mucosa and also require repair in theatre by a trained clinician.

There are several risk factors for perineal tears, including being a first-time mother, having a large baby, experiencing a precipitate labour, and having a shoulder dystocia or forceps delivery. It is important for healthcare providers to be aware of these risk factors and to provide appropriate care and management during childbirth to minimize the risk of perineal tears. By following the RCOG guidelines and providing timely and effective treatment, healthcare providers can help ensure the best possible outcomes for both mother and baby.

Breastfeeding-Related Nipple Conditions: Symptoms and Treatments

Breastfeeding can lead to various nipple conditions that can cause discomfort and pain for both the mother and the infant. Here are some common nipple conditions and their symptoms:

1. Nipple Thrush: This fungal infection is transmitted from the mother to the infant through breastfeeding. Symptoms include bilateral sharp burning pains in the nipple and retroareolar tissue, red and swollen areas, severe itching, nipple inflammation, and fissuring. Both the mother and the baby should be treated with topical miconazole and oral miconazole gel, respectively.

2. Psoriasis: Psoriasis of the nipple and breast presents with raised red plaques that are well demarcated and easily separated from adjacent skin, with an overlying lacy scale.

3. Blocked Duct: This common problem presents with unilateral nipple pain and a small, round white area at the end of the nipple.

4. Nipple Eczema: Eczema of the nipple can cause a red, scaly rash with thickened lichenoid areas, usually sparing the base of the nipple. It is less likely in this scenario, given the white patches found in the infant’s mouth, suggesting transmission of infection from the mother.

5. Paget’s Disease of the Nipple: Symptoms include erythema, inflammation, burning pain, ulceration, erosions of the skin, and bleeding, usually affecting one side only.

It is important to seek medical attention if any of these symptoms persist or worsen.

A category 2 caesarean section is the best management for a woman with an undiagnosed breech birth in labour who is not fully dilated. The decision to perform the caesarean section should be made within 75 minutes and the procedure should be arranged accordingly. Adopting an all-fours position or attempting external cephalic version with enhanced monitoring are not appropriate in this case. McRoberts manoeuvre is also not the correct management for breech birth.

Caesarean Section: Types, Indications, and Risks

Caesarean section, also known as C-section, is a surgical procedure that involves delivering a baby through an incision in the mother’s abdomen and uterus. In recent years, the rate of C-section has increased significantly due to an increased fear of litigation. There are two main types of C-section: lower segment C-section, which comprises 99% of cases, and classic C-section, which involves a longitudinal incision in the upper segment of the uterus.

C-section may be indicated for various reasons, including absolute cephalopelvic disproportion, placenta praevia grades 3/4, pre-eclampsia, post-maturity, IUGR, fetal distress in labor/prolapsed cord, failure of labor to progress, malpresentations, placental abruption, vaginal infection, and cervical cancer. The urgency of C-section may be categorized into four categories, with Category 1 being the most urgent and Category 4 being elective.

It is important for clinicians to inform women of the serious and frequent risks associated with C-section, including emergency hysterectomy, need for further surgery, admission to intensive care unit, thromboembolic disease, bladder injury, ureteric injury, and death. C-section may also increase the risk of uterine rupture, antepartum stillbirth, placenta praevia, and placenta accreta in subsequent pregnancies. Other complications may include persistent wound and abdominal discomfort, increased risk of repeat C-section, readmission to hospital, haemorrhage, infection, and fetal lacerations.

Vaginal birth after C-section (VBAC) may be an appropriate method of delivery for pregnant women with a single previous C-section delivery, except for those with previous uterine rupture or classical C-section scar. The success rate of VBAC is around 70-75%.

Breast Conditions in Lactating Women

Lactating women may experience various breast conditions, including mastitis, breast abscess, cellulitis, engorged breasts, and full breasts.

Mastitis is typically caused by a blocked duct or ascending infection from nipple trauma during breastfeeding. Symptoms include unilateral pain, breast engorgement, and erythema. Treatment involves analgesia, reassurance, and continuing breastfeeding. Antibiotics may be necessary if symptoms persist or a milk culture is positive.

Breast abscess presents as a painful lump in the breast tissue, often with systemic symptoms such as fever and malaise. Immediate treatment is necessary to prevent septicaemia.

Cellulitis is an acute bacterial infection of the breast skin, presenting with erythema, tenderness, swelling, and blister formation. Non-specific symptoms such as rigors, fevers, and malaise may also occur.

Engorged breasts can be primary or secondary, causing bilateral breast pain and engorgement. The skin may appear shiny, and the nipple may appear flat due to stretching.

Full breasts are associated with lactation and cause warm, heavy, and hard breasts. This condition typically occurs between the 2nd and 6th day postpartum.

To determine if induction is necessary, the Bishop scoring system evaluates cervical characteristics such as position, consistency, effacement, dilation, and foetal station. If the score is less than 5, induction is likely required. However, if the score is above 9, spontaneous labour is expected.

Induction of labour is a process where labour is artificially started and is required in about 20% of pregnancies. It is indicated in cases of prolonged pregnancy, prelabour premature rupture of the membranes, maternal medical problems, diabetic mother over 38 weeks, pre-eclampsia, obstetric cholestasis, and intrauterine fetal death. The Bishop score is used to assess whether induction of labour is necessary and includes cervical position, consistency, effacement, dilation, and fetal station. A score of less than 5 indicates that labour is unlikely to start without induction, while a score of 8 or more indicates a high chance of spontaneous labour or response to interventions made to induce labour.

Possible methods of induction include membrane sweep, vaginal prostaglandin E2, oral prostaglandin E1, maternal oxytocin infusion, amniotomy, and cervical ripening balloon. The NICE guidelines recommend vaginal prostaglandins or oral misoprostol if the Bishop score is less than or equal to 6, while amniotomy and an intravenous oxytocin infusion are recommended if the score is greater than 6.

The main complication of induction of labour is uterine hyperstimulation, which refers to prolonged and frequent uterine contractions that can interrupt blood flow to the intervillous space and result in fetal hypoxemia and acidemia. Uterine rupture is a rare but serious complication. Management includes removing vaginal prostaglandins and stopping the oxytocin infusion if one has been started, and considering tocolysis.

Factor V Leiden is a genetic condition that causes resistance to the breakdown of Factor V by activated Protein C, leading to an increased risk of blood clots. The RCOG has issued guidelines (Green-top Guideline No.37a) for preventing blood clots in pregnant women with this condition. As this patient has a history of VTE, she is at high risk during and after pregnancy and requires both antenatal and postnatal thromboprophylaxis. It is important to note that postnatal prophylaxis must be given for six weeks following antenatal prophylaxis.

Venous Thromboembolism in Pregnancy: Risk Assessment and Prophylactic Measures

Pregnancy increases the risk of developing venous thromboembolism (VTE), a condition that can be life-threatening for both the mother and the fetus. To prevent VTE, it is important to assess a woman’s individual risk during pregnancy and initiate appropriate prophylactic measures. This risk assessment should be done at the first antenatal booking and on any subsequent hospital admission.

Women with a previous history of VTE are automatically considered high risk and require low molecular weight heparin throughout the antenatal period, as well as input from experts. Women at intermediate risk due to hospitalization, surgery, co-morbidities, or thrombophilia should also be considered for antenatal prophylactic low molecular weight heparin.

The risk assessment at booking should include factors that increase the likelihood of developing VTE, such as age over 35, body mass index over 30, parity over 3, smoking, gross varicose veins, current pre-eclampsia, immobility, family history of unprovoked VTE, low-risk thrombophilia, multiple pregnancy, and IVF pregnancy.

If a woman has four or more risk factors, immediate treatment with low molecular weight heparin should be initiated and continued until six weeks postnatal. If a woman has three risk factors, low molecular weight heparin should be initiated from 28 weeks and continued until six weeks postnatal.

If a diagnosis of deep vein thrombosis (DVT) is made shortly before delivery, anticoagulation treatment should be continued for at least three months, as in other patients with provoked DVTs. Low molecular weight heparin is the treatment of choice for VTE prophylaxis in pregnancy, while direct oral anticoagulants (DOACs) and warfarin should be avoided.

In summary, a thorough risk assessment and appropriate prophylactic measures can help prevent VTE in pregnancy, which is crucial for the health and safety of both the mother and the fetus.

According to the guidelines of the Royal College, women who experience a fever of over 38 degrees Celsius during labor should be administered benzylpenicillin as a prophylactic measure against GBS.

Group B Streptococcus (GBS) is a common cause of severe infection in newborns. It is estimated that 20-40% of mothers carry GBS in their bowel flora, which can be passed on to their infants during labor and lead to serious infections. Prematurity, prolonged rupture of membranes, previous sibling GBS infection, and maternal pyrexia are all risk factors for GBS infection. The Royal College of Obstetricians and Gynaecologists (RCOG) has published guidelines on GBS management, which include not offering universal screening for GBS to all women and not offering screening based on maternal request. Women who have had GBS detected in a previous pregnancy should be offered intrapartum antibiotic prophylaxis (IAP) or testing in late pregnancy and antibiotics if still positive. IAP should also be offered to women with a previous baby with GBS disease, women in preterm labor, and women with a fever during labor. Benzylpenicillin is the preferred antibiotic for GBS prophylaxis.

Antibiotics for Urinary Tract Infections in Pregnancy: A Guide

Urinary tract infections (UTIs) are common in pregnancy and require prompt treatment to prevent complications. When choosing an antibiotic, it is important to consider its safety for both the mother and the developing fetus. Here is a guide to some commonly used antibiotics for UTIs in pregnancy.

Nitrofurantoin: This is the first-line antibiotic recommended by NICE guidelines for UTIs in pregnancy. It is safe to use, but should be avoided near term as it can cause neonatal haemolysis. It should also not be used during breastfeeding. Side-effects may include agranulocytosis, arthralgia, anaemia, chest pain and diarrhoea.

Erythromycin: This antibiotic is not routinely used for UTIs in pregnancy, but is considered safe for both mother and fetus.

cephalexin: This beta-lactam antibiotic is licensed as second-line treatment for UTIs in pregnancy. It is safe to use and has no documented fetal complications.

Co-amoxiclav: This broad-spectrum antibiotic is not used for UTIs in pregnancy, but is safe for both mother and fetus.

Trimethoprim: This antibiotic is no longer recommended for UTIs in pregnancy due to its interference with folate metabolism. If no other options are available, it can be given with increased folate intake.

Remember to always consult with a healthcare professional before taking any medication during pregnancy.

When a patient presents with symptoms that suggest placental abruption, a transabdominal ultrasound scan is the most appropriate first-line investigation. This is especially true if the patient has risk factors such as pre-eclampsia and age over 35. The ultrasound scan can serve a dual purpose by assessing the position of the placenta and excluding placenta praevia, as well as assessing the integrity of the placenta and detecting any blood collection or haematoma that may indicate placental abruption. However, in some cases, the ultrasound scan may be normal even in the presence of placental abruption. In such cases, a magnetic resonance imaging (MRI) scan may be necessary for a more accurate diagnosis.

Before performing a bimanual pelvic examination, it is essential to rule out placenta praevia, as this can lead to significant haemorrhage and fetal and maternal compromise. A full blood count is also necessary to assess the extent of bleeding and anaemia, but it is not diagnostic of placental abruption.

An abdominal CT scan is not used as a first-line investigation for all women with antepartum haemorrhage, as it exposes the fetus to a significant radiation dose. It is only used in the assessment of pregnant women who have suffered traumatic injuries. Urinalysis is important in the assessment of women with antepartum haemorrhage, as it can detect genitourinary infections, but it does not aid in the diagnosis of placental abruption.

The first stage of labour begins with the onset of true labour and ends when the cervix is fully dilated at 10cm. During this stage, regular contractions occur and the cervix gradually dilates. It is important to note that although 4 cm and 6cm cervical dilation occur during this stage, it does not end until the cervix is fully effaced at 10cm. The second stage of labour ends with the birth of the foetus, not the first.

Labour is divided into three stages, with the first stage beginning from the onset of true labour until the cervix is fully dilated. This stage is further divided into two phases: the latent phase and the active phase. The latent phase involves dilation of the cervix from 0-3 cm and typically lasts around 6 hours. The active phase involves dilation from 3-10 cm and progresses at a rate of approximately 1 cm per hour. In primigravidas, this stage can last between 10-16 hours.

During this stage, the baby’s presentation is important to note. Approximately 90% of babies present in the vertex position, with the head entering the pelvis in an occipito-lateral position. The head typically delivers in an occipito-anterior position.

The MMR vaccine, which contains live attenuated virus, should not be given to women who are pregnant or trying to conceive. It is recommended that women avoid getting pregnant for at least 28 days after receiving the vaccine. If a pregnant woman is not immune to MMR, she should avoid contact with individuals who have the disease. In the event that a woman receives the MMR vaccine unintentionally during the periconception period or early pregnancy, termination of pregnancy is not necessary. This information is based on the guidelines provided by the American College of Obstetricians and Gynecologists.

Rubella and Pregnancy: Risks, Features, Diagnosis, and Management

Rubella, also known as German measles, is a viral infection caused by the togavirus. Thanks to the introduction of the MMR vaccine, it is now rare. However, if contracted during pregnancy, there is a risk of congenital rubella syndrome, which can cause serious harm to the fetus. It is important to note that the incubation period is 14-21 days, and individuals are infectious from 7 days before symptoms appear to 4 days after the onset of the rash.

The risk of damage to the fetus is highest in the first 8-10 weeks of pregnancy, with a risk as high as 90%. However, damage is rare after 16 weeks. Features of congenital rubella syndrome include sensorineural deafness, congenital cataracts, congenital heart disease (e.g. patent ductus arteriosus), growth retardation, hepatosplenomegaly, purpuric skin lesions, ‘salt and pepper’ chorioretinitis, microphthalmia, and cerebral palsy.

If a suspected case of rubella in pregnancy arises, it should be discussed immediately with the local Health Protection Unit (HPU) as type/timing of investigations may vary. IgM antibodies are raised in women recently exposed to the virus. It should be noted that it is very difficult to distinguish rubella from parvovirus B19 clinically. Therefore, it is important to also check parvovirus B19 serology as there is a 30% risk of transplacental infection, with a 5-10% risk of fetal loss.

If a woman is tested at any point and no immunity is demonstrated, they should be advised to keep away from people who might have rubella. Non-immune mothers should be offered the MMR vaccination in the post-natal period. However, MMR vaccines should not be administered to women known to be pregnant or attempting to become pregnant.

Guidelines for Managing Diabetes in Pregnancy

Managing diabetes in pregnancy requires close monitoring to reduce the risk of maternal and fetal complications. The National Institute for Health and Care Excellence (NICE) has provided guidelines for healthcare professionals to follow when caring for women with diabetes during pregnancy.

Joint Diabetes and Antenatal Clinic Visits

Women with diabetes should be seen in a Joint Diabetes and Antenatal Clinic every one to two weeks throughout their pregnancy. This ensures that any problems are addressed promptly and appropriately.

Serial Fetal Scanning

Women with diabetes should be offered serial fetal scanning from 26 weeks’ gestation every four weeks. This helps to monitor and prevent complications such as macrosomia, polyhydramnios, stillbirth, and congenital anomalies.

Delivery by Induction of Labour or Caesarean Section

Women with diabetes should be advised to deliver by induction of labour or Caesarean section between 38 and 39+6 weeks’ gestation. This is because diabetes is associated with an increased risk of stillbirth, and the risk is managed by inducing labour when the pregnancy reaches term.

Induction at 41+6 Weeks’ Gestation

Women with diabetes who do not opt for an elective induction or a Caesarean section between 37+0 to 38+6 weeks’ gestation and wish to await spontaneous labour should be warned of the risks of stillbirth and neonatal complications. In cases of prolonged pregnancy, the patient should be offered induction by, at most, 40+6 weeks’ gestation.

Retinal Assessment

All women with pre-existing diabetes should be offered retinal assessment at 16–20 weeks’ gestation. If initial screening is normal, then they are offered a second retinal screening test at 28 weeks’ gestation. If the booking retinal screening is abnormal, then a repeat retinal screening test is offered to these women earlier than 28 weeks, usually between 16 and 20 weeks’ gestation.

Intrahepatic cholestasis of pregnancy is known to increase the risk of stillbirth, which is why doctors usually recommend inducing labor at 37-38 weeks of gestation. Although some studies suggest that this may no longer be the case, the general consensus is that the risk of stillbirth is still relatively high. Therefore, early induction of labor is still advised.

While advanced maternal age is a risk factor for stillbirth, being 34 years old is not considered to be in the category of older maternal age, which is defined as 35 years old or older.

Although there may be a genetic component to stillbirths, having a step-sister with a history of stillbirth does not constitute a family history of the condition. This is because step-siblings are not biologically related, but rather connected through marriage.

Lamotrigine is considered the safest anti-epileptic medication to use during pregnancy, and there is no evidence to suggest that it increases the risk of stillbirth.

Intrahepatic Cholestasis of Pregnancy: Symptoms and Management

Intrahepatic cholestasis of pregnancy, also known as obstetric cholestasis, is a condition that affects approximately 1% of pregnancies in the UK. It is characterized by intense itching, particularly on the palms, soles, and abdomen, and may also result in clinically detectable jaundice in around 20% of patients. Raised bilirubin levels are seen in over 90% of cases.

The management of intrahepatic cholestasis of pregnancy typically involves induction of labor at 37-38 weeks, although this practice may not be evidence-based. Ursodeoxycholic acid is also widely used, although the evidence base for its effectiveness is not clear. Additionally, vitamin K supplementation may be recommended.

It is important to note that the recurrence rate of intrahepatic cholestasis of pregnancy in subsequent pregnancies is high, ranging from 45-90%. Therefore, close monitoring and management are necessary for women who have experienced this condition in the past.

In the event of cord prolapse, which occurs when the umbilical cord descends below the presenting part of the fetus after membrane rupture, fetal hypoxia and death can occur due to cord compression or spasm. To prevent compression, tocolytics should be administered and a Caesarean delivery should be performed. The patient should be advised to assume an all-fours position. It is important not to push the cord back into the uterus. The preferred method of delivery is an immediate Caesarean section.

Understanding Umbilical Cord Prolapse

Umbilical cord prolapse is a rare but serious complication that can occur during delivery. It happens when the umbilical cord descends ahead of the presenting part of the fetus, which can lead to compression or spasm of the cord. This can cause fetal hypoxia and potentially irreversible damage or death. Certain factors increase the risk of cord prolapse, such as prematurity, multiparity, polyhydramnios, twin pregnancy, cephalopelvic disproportion, and abnormal presentations like breech or transverse lie.

Around half of all cord prolapses occur when the membranes are artificially ruptured. Diagnosis is usually made when the fetal heart rate becomes abnormal and the cord is palpable vaginally or visible beyond the introitus. Cord prolapse is an obstetric emergency that requires immediate management. The presenting part of the fetus may be pushed back into the uterus to avoid compression, and the cord should be kept warm and moist to prevent vasospasm. The patient may be asked to go on all fours or assume the left lateral position until preparations for an immediate caesarian section have been carried out. Tocolytics may be used to reduce uterine contractions, and retrofilling the bladder with saline can help elevate the presenting part. Although caesarian section is the usual first-line method of delivery, an instrumental vaginal delivery may be possible if the cervix is fully dilated and the head is low.

In conclusion, umbilical cord prolapse is a rare but serious complication that requires prompt recognition and management. Understanding the risk factors and appropriate interventions can help reduce the incidence of fetal mortality associated with this condition.

Antiretroviral Therapy Options for Pregnant Women with HIV

The British HIV Association recommends that all pregnant women who are HIV-positive should be started on combined antiretroviral therapy in the second trimester and continue it lifelong. This therapy consists of three agents. Even if the viral load is low, antiretroviral therapy is still recommended.

For women who refuse combined antiretroviral therapy, zidovudine monotherapy can be offered if the patient has a CD4 count of > 350 and a viral load of < 10 000 copies/ml and agrees to a Caesarean section. This option is less effective than combined therapy but can still be considered. If zidovudine monotherapy is chosen, it should be started in the second trimester and continued until delivery. During delivery, a zidovudine infusion should be running. If the viral load remains < 50 copies/ml, a planned vaginal delivery can be considered.

If the baby loses more than 10% of his birth weight in the first week, immediate measures must be taken to ensure proper feeding.

Breastfeeding Problems and Their Management

Breastfeeding is a natural process, but it can come with its own set of challenges. Some of the minor problems that breastfeeding mothers may encounter include frequent feeding, nipple pain, blocked ducts, and nipple candidiasis. These issues can be managed by seeking advice on proper positioning, trying breast massage, and using appropriate medication.

Mastitis is a more serious problem that affects around 1 in 10 breastfeeding women. It is characterized by symptoms such as fever, nipple fissure, and persistent pain. Treatment involves the use of antibiotics, such as flucloxacillin, for 10-14 days. Breastfeeding or expressing milk should continue during treatment to prevent complications such as breast abscess.

Breast engorgement is another common problem that causes breast pain in breastfeeding women. It occurs in the first few days after birth and affects both breasts. Hand expression of milk can help relieve the discomfort of engorgement. Raynaud’s disease of the nipple is a less common problem that causes nipple pain and blanching. Treatment involves minimizing exposure to cold, using heat packs, and avoiding caffeine and smoking.

If a breastfed baby loses more than 10% of their birth weight in the first week of life, it may be a sign of poor weight gain. This should prompt consideration of the above breastfeeding problems and an expert review of feeding. Monitoring of weight should continue until weight gain is satisfactory.

The correct result for the quadruple test in a patient with Down’s syndrome is a decrease in AFP and oestriol, and an increase in hCG and inhibin A. This test is recommended by NICE for pregnant patients between 15-20 weeks gestation. If the screening test shows an increased risk, further diagnostic tests such as NIPT, amniocentesis, or chorionic villous sampling may be offered to confirm the diagnosis. It is important to note that a pattern of decreased AFP, decreased oestriol, decreased hCG, and normal inhibin A is suggestive of an increased risk of Edward’s syndrome. Increased AFP, increased oestriol, decreased hCG, and decreased inhibin A or any other combination of abnormal results may not be indicative of Down’s syndrome.

NICE updated guidelines on antenatal care in 2021, recommending the combined test for screening for Down’s syndrome between 11-13+6 weeks. The test includes nuchal translucency measurement, serum B-HCG, and pregnancy-associated plasma protein A (PAPP-A). The quadruple test is offered between 15-20 weeks for women who book later in pregnancy. Results are interpreted as either a ‘lower chance’ or ‘higher chance’ of chromosomal abnormalities. If a woman receives a ‘higher chance’ result, she may be offered a non-invasive prenatal screening test (NIPT) or a diagnostic test. NIPT analyzes cell-free fetal DNA in the mother’s blood and has high sensitivity and specificity for detecting chromosomal abnormalities. Private companies offer NIPT screening from 10 weeks gestation.

When dealing with preterm premature rupture of membranes (PPROM), it’s important to consider the possibility of chorioamnionitis in women who exhibit a combination of maternal pyrexia, maternal tachycardia, and fetal tachycardia. While other conditions like pelvic inflammatory disease and urinary tract infections may also be considered, chorioamnionitis is the most probable diagnosis. Immediate cesarean section and intravenous antibiotics will likely be necessary.

Understanding Chorioamnionitis

Chorioamnionitis is a serious medical condition that can affect both the mother and the foetus during pregnancy. It is caused by a bacterial infection that affects the amniotic fluid, membranes, and placenta. This condition is considered a medical emergency and can be life-threatening if not treated promptly. It is more likely to occur when the membranes rupture prematurely, but it can also happen when the membranes are still intact.

Prompt delivery of the foetus is crucial in treating chorioamnionitis, and a cesarean section may be necessary. Intravenous antibiotics are also administered to help fight the infection. This condition affects up to 5% of all pregnancies, and it is important for pregnant women to be aware of the symptoms and seek medical attention immediately if they suspect they may have chorioamnionitis.

When a pregnant woman reports reduced fetal movements, the first step should be to use a handheld Doppler to confirm the fetal heartbeat. Most women start feeling the baby move around 20 weeks of gestation, and reduced movements at 30 weeks could indicate fetal distress. The Royal College of Obstetrics and Gynaecology recommends that doctors attempt to listen to the fetal heart rate in any woman with reduced fetal movements. Checking a urine sample for a UTI is not a priority in this situation, and performing an ultrasound should only be done after confirming fetal viability with a handheld Doppler. Reassuring the woman that reduced movements are normal is incorrect, as it is abnormal at this stage of pregnancy. CTG is also not necessary until fetal viability has been confirmed with a Doppler.

Understanding Reduced Fetal Movements

Introduction:
Reduced fetal movements can indicate fetal distress and are a response to chronic hypoxia in utero. This can lead to stillbirth and fetal growth restriction. It is believed that placental insufficiency may also be linked to reduced fetal movements.

Physiology:
Quickening is the first onset of fetal movements, which usually occurs between 18-20 weeks gestation and increases until 32 weeks gestation. Multiparous women may experience fetal movements sooner. Fetal movements should not reduce towards the end of pregnancy. There is no established definition for what constitutes reduced fetal movements, but less than 10 movements within 2 hours (in pregnancies past 28 weeks gestation) is an indication for further assessment.

Epidemiology:
Reduced fetal movements affect up to 15% of pregnancies, with 3-5% of pregnant women having recurrent presentations with RFM. Fetal movements should be established by 24 weeks gestation.

Risk factors for reduced fetal movements:
Posture, distraction, placental position, medication, fetal position, body habitus, amniotic fluid volume, and fetal size can all affect fetal movement awareness.

Investigations:
Fetal movements are usually based on maternal perception, but can also be objectively assessed using handheld Doppler or ultrasonography. Investigations are dependent on gestation at onset of RFM. If concern remains, despite normal CTG, urgent (within 24 hours) ultrasound can be used.

Prognosis:
Reduced fetal movements can represent fetal distress, but in 70% of pregnancies with a single episode of reduced fetal movement, there is no onward complication. However, between 40-55% of women who suffer from stillbirth experience reduced fetal movements prior to diagnosis. Recurrent RFM requires further investigations to consider structural or genetic fetal abnormalities.

Medical treatments available for managing postpartum haemorrhage caused by uterine atony include oxytocin, ergometrine, carboprost, and misoprostol.

The correct option for this patient is IV oxytocin. The patient is experiencing primary postpartum haemorrhage (PPH), which is characterized by the loss of more than 500 ml of blood within 24 hours of delivering the baby. Uterine atony, which occurs when the uterus fails to contract after the placenta is delivered, is the most common cause of PPH. The initial steps in managing this condition involve an ABCDE approach, establishing IV access, and resuscitation. Mechanical palpation of the uterine fundus (rubbing the uterus) is also done to stimulate contractions, but it has not been successful in this case. The next step is pharmacological management, which involves administering IV oxytocin.

IM carboprost is not the correct option. Although it is another medical management option, it should be avoided in patients with asthma, which this patient has.

IV carboprost is also not the correct option. Carboprost is given intramuscularly, not intravenously. Additionally, it should be avoided in patients with asthma.

Understanding Postpartum Haemorrhage

Postpartum haemorrhage (PPH) is a condition where a woman experiences blood loss of more than 500 ml after giving birth vaginally. It can be classified as primary or secondary. Primary PPH occurs within 24 hours after delivery and is caused by the 4 Ts: tone, trauma, tissue, and thrombin. The most common cause is uterine atony. Risk factors for primary PPH include previous PPH, prolonged labour, pre-eclampsia, increased maternal age, emergency Caesarean section, and placenta praevia.

In managing PPH, it is important to involve senior staff immediately and follow the ABC approach. This includes two peripheral cannulae, lying the woman flat, blood tests, and commencing a warmed crystalloid infusion. Mechanical interventions such as rubbing up the fundus and catheterisation are also done. Medical interventions include IV oxytocin, ergometrine, carboprost, and misoprostol. Surgical options such as intrauterine balloon tamponade, B-Lynch suture, ligation of uterine arteries, and hysterectomy may be considered if medical options fail to control the bleeding.

Secondary PPH occurs between 24 hours to 6 weeks after delivery and is typically due to retained placental tissue or endometritis. It is important to understand the causes and risk factors of PPH to prevent and manage this life-threatening emergency effectively.